Publications

03-28 10:06
 
SMS messaging to improve ART adherence: perspectives of pregnant HIV-infected women in Kenya on HIV-related message content
03-28 10:06
 
Evaluation of mHealth strategies to optimize adherence and efficacy of Option B+ prevention of mother-to-child HIV transmission: Rationale, design and methods of a 3-armed randomized controlled trial
03-28 10:06
 
Definition of Fiducial Points in the Normal Seismocardiogram
03-28 10:06
 
Intranasal Dexmedetomidine as a Sedative Premedication for Patients Undergoing Suspension Laryngoscopy: A Randomized Double-Blind Study
03-28 10:06
 
Optimal timing for the administration of intranasal dexmedetomidine for premedication in children
03-28 10:06
 
Bioavailability of dexmedetomidine after intranasal administration
03-28 10:06
 
A randomised comparison of two intranasal dexmedetomidine doses for premedication in children
03-28 10:06
 
Analgesic and sedative effects of intranasal dexmedetomidine in third molar surgery under local anaesthesia
03-28 10:06
 
Evaluation of a ketogenic diet for improvement of neurological recovery in individuals with acute spinal cord injury: study protocol for a randomized controlled trial
03-28 10:06
 
Effect of alendronate and vitamin D₃ on fractional calcium absorption in a double-blind, randomized, placebo-controlled trial in postmenopausal osteoporotic women
03-28 10:06
 
Oral anticoagulant and antiplatelet therapy and peripheral arterial disease
03-28 10:06
 
Treatment failure and costs in patients with methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections: a South Texas Ambulatory Research Network (STARNet) study
03-28 10:06
 
Benchmarking trial between France and Australia comparing management of primary rectal cancer beyond TME and locally recurrent rectal cancer (PelviCare Trial): rationale and design
03-28 10:06
 
Defining an Intraoperative Hypotension Threshold in Association with Stroke in Cardiac Surgery
03-28 10:06
 
A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin-noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine
03-28 10:06
 
Incorporation of n-3 PUFA and γ-linolenic acid in blood lipids and red blood cell lipids together with their influence on disease activity in patients with chronic inflammatory arthritis--a randomized controlled human intervention trial
03-28 10:06
 
A prospective trial of GreenLight PVP (HPS120) versus transurethral resection of the prostate in the treatment of lower urinary tract symptoms in Ontario, Canada
03-28 10:06
 
Efficacy and tolerability of vortioxetine versus agomelatine, categorized by previous treatment, in patients with major depressive disorder switched after an inadequate response
03-28 10:06
 
Photoselective vaporization for the treatment of benign prostatic hyperplasia
03-28 10:06
 
Acceptability and efficacy of an emollient containing ceramide-precursor lipids and moisturizing factors for atopic dermatitis in pediatric patients
03-28 10:06
 
Review of therapeutic agents for burns pruritus and protocols for management in adult and paediatric patients using the GRADE classification
03-28 10:06
 
Pruritus in Systemic Diseases: A Review of Etiological Factors and New Treatment Modalities
03-28 10:06
 
Emollient treatment of atopic dermatitis: latest evidence and clinical considerations
03-28 10:06
 
Keratolytics and emollients and their role in the therapy of psoriasis: a systematic review
03-28 10:06
 
Music Therapy for Symptom Management After Autologous Stem Cell Transplantation: Results From a Randomized Study

Clinical Research News

Applying for a Paediatric investigation plan (PIP): review of the EMA guidelines
Considerations for the Use of Real-World Data and Real-World Evidence To Support Regulatory Decision-Making for Drug and Biological Products
Submission of comments on ICH E6 (R3) Guideline for Good Clinical Practice(GCP) - Step 2b 
ICH E6(R3) Good Clinical Practice guidance - Step 2 Public Consultation
The study of the new investigational drug for acute myeloid leukemia and myelodysplastic syndrome
Open Label study of entrectinib in ROS1 gene fusion-positive rare adult, paediatric and teenage/young adult cancers
Gasherbrum Bio, Inc is starting the study of GSBR-1290 drug in overweight or obese healthy adults

Upcoming Clinical Trials

Clinical Research Jobs

All jobs

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe